NMR & EPR Biopharma Solutions

Production on Demand

Controlling chemical reactions with artificial intelligence

The PIPAc Project

The companies NovAliX, Alysophil, De Dietrich Process Systems and Bruker have joined forces to bring to market a new approach to active pharmaceutical ingredient (API) production. The partnership will leverage its complementary skills to provide a complete, standalone, and location-independent API manufacturing solution to a pharmaceutical company or contract manufacturing organization.

More Information

Video

Artificial intelligence can learn to control a car. Can AI control a chemical reaction?

News

  • PIPAc collaboration enables new compact, mobile and frugal approach to active pharmaceutical ingredient (API) manufacturing
  • Alysophil demonstrates first real-world solution in AI- powered autonomous chemical synthesis for APIs - within PIPAc project

Download Technical Notes

Input value is invalid.

Contact Information

Please enter your first name
Please enter your last name
Please enter a valid e-mail address
Please enter your Company/Institution

Additional Information

I would like to attend *

Anmeldung für die Teilnahme:

Bitte wählen *

I would like to attend:

Your selection

I would like to attend

I would like to attend:

Your selection

I would like to attend:

Your selection

I would like to attend:

Your selection

 

Privacy Settings

To learn how Bruker handles my personal data, please read Bruker´s Privacy Notice and  Terms of Use.

* Please fill out the mandatory fields.

I agree to share my contact details with Bruker Corporation and its affiliates within the Bruker Group for the purpose of proceeding with my registration.

Thank you for your interest